You are here:
View which countries have been approved for each type of Gavi support as of 3 March 2015
Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here